Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 AZN | AstraZeneca PLC | $300.7b | $203.88 | +0.2% | 496.3K |
 TMO | Thermo Fisher Scientific, Inc. | $178.3b | $486.36 | -1.0% | 648.7K |
 DHR | Danaher Corporation | $130.1b | $191.86 | +0.4% | 1.1M |
 WAT | Waters Corp | $28.8b | $304.27 | +0.0% | 213.2K |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $13.4b | $73.01 | -0.2% | 165.4K |
 GH | Guardant Health, Inc. Common Stock | $11.3b | $90.31 | -3.8% | 469.7K |
 RVTY | Revvity, Inc. | $9.5b | $87.85 | -1.2% | 176.5K |
 TECH | Bio-Techne Corp. | $8.1b | $53.17 | +0.1% | 582.6K |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $7.7b | $311.47 | +0.3% | 136.4K |
 NUVL | Nuvalent, Inc. Class A Common Stock | $7.6b | $104.85 | -0.6% | 375.1K |
 TEM | Tempus AI, Inc. Class A Common Stock | $7.6b | $48.01 | +1.3% | 1.5M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $6.5b | $85.70 | +0.4% | 144.2K |
 CAI | Caris Life Sciences, Inc. Common Stock | $4.8b | $19.39 | +0.5% | 549.8K |
 LNTH | Lantheus Holdings, Inc | $4.8b | $76.09 | -0.0% | 126.1K |
 DYN | Dyne Therapeutics, Inc. Common Stock | $2.8b | $18.60 | -1.3% | 554.0K |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $2.8b | $32.67 | -0.2% | 161.6K |
 TWST | Twist Bioscience Corporation Common Stock | $2.7b | $51.70 | +3.0% | 277.6K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $2.0b | $14.35 | -3.1% | 535.9K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $1.7b | $66.61 | +0.6% | 161.6K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.4b | $29.36 | +2.3% | 227.2K |
 CDNA | CareDx, Inc. | $0.8b | $18.14 | -0.9% | 90.9K |
 CSTL | Castle Biosciences, Inc. Common Stock | $0.7b | $25.21 | +1.5% | 56.5K |
 ANRO | Alto Neuroscience Inc. | $0.6b | $21.63 | -0.3% | 97.3K |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.6b | $4.54 | +0.3% | 152.0K |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $434.1m | $3.33 | +0.6% | 111.9K |
 AURA | Aura Biosciences, Inc. Common Stock | $394.2m | $6.87 | +5.0% | 275.2K |
 LAB | Standard BioTools Inc. Common Stock | $359.5m | $0.88 | -3.1% | 828.6K |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $336.1m | $4.84 | -3.9% | 70.4K |
 AVXL | Anavex Life Sciences | $261.3m | $3.02 | +1.2% | 335.0K |
 ACIU | AC Immune SA | $260.5m | $2.76 | -0.1% | 40.1K |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $259.5m | $4.91 | -0.4% | 59.9K |
 OABI | OmniAb, Inc. Common Stock | $225.9m | $1.54 | +0.3% | 129.7K |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $198.4m | $7.74 | +2.3% | 32.7K |
 PRLD | Prelude Therapeutics Incorporated | $193.4m | $3.79 | +9.4% | 207.2K |
 QTRX | Quanterix Corporation Common Stock | $161.0m | $3.64 | -3.9% | 158.9K |
 QSI | Quantum-Si Incorporated Class A Common Stock | $159.6m | $0.74 | -0.8% | 1.0M |
 BDSX | Biodesix, Inc. Common Stock | $135.9m | $15.70 | +4.1% | 69.7K |
 MDXH | MDxHealth SA Ordinary Shares | $117.6m | $2.05 | -5.1% | 270.7K |
 SEER | Seer, Inc. Class A Common Stock | $94.8m | $1.71 | +0.6% | 10.9K |
 CSBR | Champions Oncology, Inc. | $81.1m | $5.71 | -1.0% | 2.1K |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $75.2m | $2.21 | +10.2% | 27.4K |
 XGN | Exagen Inc. Common Stock | $63.7m | $3.15 | +2.9% | 102.1K |
 IBIO | iBio, Inc. Common Stock | $59.1m | $2.06 | +4.0% | 296.8K |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $50.0m | $1.61 | +6.3% | 463.3K |
 CCEL | Cryo-Cell International Inc. | $27.5m | $3.59 | -1.4% | 7.4K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $17.4m | $4.61 | +3.4% | 17.2K |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $16.7m | $1.19 | +2.6% | 153.7K |
 ADVB | Advanced Biomed Inc. Common Stock | $6.1m | $4.43 | -2.5% | 5.6K |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $5.1m | $2.00 | -1.9% | 11.4K |